US Patent Issued to Celyntra Therapeutics on April 8 for "Compositions and methods for targeting, editing, or modifying genes" (Austrian, American, Danish Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,270,043, issued on April 8, was assigned to Celyntra Therapeutics SA (Mont-Saint-Guiberi, Belgium).

"Compositions and methods for targeting, editing, or modifying genes" was invented by Andrea Barghetti (Copenhagen, Denmark), Roland Baumgartner (Angern an der March, Austria), Tanya Warnecke (Boulder, Colo.), Kurt Marshall (Boulder, Colo.), John Schiel (Westminster, Colo.) and Alyssa Carlson (Westminster, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are nucleic acids useful as guide nucleic acids (gNAs), e.g., guide ribonucleic acids (gRNAs), in a CRISPR system wherein the guide nucleic acids contain one or more modifications to o...